Skip to ContentSkip to Navigation
Research Medical Microbiology and Infection Prevention
University Medical Center Groningen

PhD ceremony Ms. H. Liu: Improvement of influenza vaccines by using a saponin-derived adjuvant

Improvement of influenza vaccines by using a saponin-derived adjuvant
19 June 2013

PhD ceremony: Ms. H. Liu, 11.00 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Improvement of influenza vaccines by using a saponin-derived adjuvant

Promotor(s): prof. A.L.W. Huckriede, prof. J.C. Wilschut

Faculty: Medical Sciences

Summary:

Effective influenza vaccines should protect individuals from influenza infection and reduce the socio-economic burden imposed by the disease. Current influenza vaccines, however, show only partial efficacy and effectiveness in healthy adults. Moreover, proof of satisfactory protection among small children and the elderly, the most vulnerable populations for influenza infection, is still lacking. In this thesis, we show that the immunogenicity and protective capacity of influenza vaccines can be significantly potentiated by the incorporation of the adjuvant GPI-0100 in the vaccine. GPI-0100 is a molecule from the bark of the soap bark tree Quillaja saponaria. In mice, influenza vaccines containing GPI-0100 elicit significantly improved immune responses of higher magnitude and better quality, when compared to those induced by the same vaccines without GPI-0100. Importantly, substantial protection of the lungs can be achieved by vaccination with GPI-0100-containing influenza vaccines at an extremely low antigen dose. This can be particularly beneficial during pandemics when vaccine demand is huge, but antigen supply limited. Therefore, GPI-0100 can help to overcome the limitations concerning immunogenicity and availability of current influenza vaccines. We also show that the performance of GPI-0100-adjuvanted influenza vaccine can be further improved by choosing an optimal antigen formulation (e.g., reconstituted viral envelopes) and route of vaccine administration (e.g., pulmonary immunisation).

Last modified:09 May 2019 11.26 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.